Work

Abstract 309: Adding nadunolimab to chemotherapy or antibody drug-conjugates (ADCs) may improve antitumor efficacy and counteract peripheral neuropathy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-309

Authors: Samuel Le Sourd, Rocio Garcia-Carbonero, Sandrine Hiret, Elin Jaensson Gyllenback, Camilla Rydberg Millrud, Lars Thorsson, Svetlana Shatunova, Irina Vetter, Hana Starobova, David Liberg

Institutions: Centre Eugène Marquis, Institut de Cancérologie de l'Ouest

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633782

Cites:

Cited by:

Related to: 10